AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
InnoCare Pharma enters a strategic research collaboration and licensing agreement with Eli Lilly to develop new medicines.
InnoCare Pharma and Eli Lilly have announced a partnership aimed at developing new medicines, with potential payments reaching about $3.35 billion. Under the agreement, InnoCare will utilize its drug discovery platform for research against multiple targets.
Company Information
Company
InnoCare Pharma
Location
Beijing, Beijing, China
About
InnoCare Pharma is a leading biopharmaceutical company that focuses on the treatment of cancer and autoimmune diseases. The company is committed to discovering, developing, and commercializing first-in-class and best-in-class drugs to address unmet medical needs in China and globally. With branches in various cities including Beijing and Hong Kong, InnoCare is actively involved in advancing innovative therapies. They aim to improve the quality of life for patients suffering from serious health conditions.
BeijingBiotechnologyHealth CareMedicalTherapeuticsPharmaceutical